Science Explorer Interactive view Map
Company · Gerrards Cross · United Kingdom

Amicus Therapeutics (United Kingdom)

amicusrx.comROR OpenAlex
Research works
73
▲ 226% vs 2013–17
Citations
509
7.0 per fractional work
Top-10% rate
6.8%
record average 16.5%
Open access
31%
world 28%

Not ranked overall: Amicus Therapeutics (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.59× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.74× its world share, 1 worksImmunology and Micro…Neuroscience: 0.47× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.32× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.10× its world share, 0 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceMaterials Science: 0.77× its world share, 1 worksMaterials ScienceHealth Professions: 1.54× its world share, 1 worksHealth ProfessionsMedicine: 2.64× its world share, 12 worksMedicineBusiness, Management and Accounting: 0.73× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 5.89× its world share, 3 worksEconomics, Econometr…Psychology: 1.70× its world share, 1 worksPsychologySocial Sciences: 0.23× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.9×. Every wedge is a field page.

Which keywords describe research at Amicus Therapeutics (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Parkinson's Disease, Enzyme Replacement Therapy, Lysosomal Storage Disorders, Metabolism, Neurodegeneration, Genetic Mutations, Glycogen and Myoclonic Disorders.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Parkinson's Disease7▲ 117×3 topics
  2. Enzyme Replacement Therapy7▲ 1501×1 topic
  3. Lysosomal Storage Disorders7▲ 1825×1 topic
  4. Metabolism2▲ 19×2 topics
  5. Neurodegeneration2▲ 31×3 topics
  6. Genetic Mutations2▲ 20×2 topics
  7. Glycogen2▲ 773×1 topic
  8. Myoclonic Disorders2▲ 773×1 topic
  9. Quality of Life2▲ 5.7×2 topics
  10. Cost-effectiveness Analysis2▲ 73×1 topic
  11. Health Utility Measures2▲ 73×1 topic
  12. Cancer Therapy1▲ 9.2×3 topics
  13. Epidemiology1▲ 1.33×5 topics
  14. Cancer1▲ 3.6×6 topics
  15. Autism Spectrum Disorders1▲ 42×2 topics
  16. COVID-191▲ 3.0×1 topic
  17. Mental Health1▲ 2.8×1 topic

Which research topics does Amicus Therapeutics (United Kingdom) publish most on?

By volume in 2022–2025: Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Health Systems, Economic Evaluations, Quality of Life and COVID-19 and Mental Health.

Lysosomal Storage Disord…7Lysosomal Storage Disorders Research: 7 fractional worksGlycogen Storage Diseases and Myoclonus: 2 fractional worksHealth Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksCOVID-19 and Mental Health1COVID-19 and Mental Health: 1 fractional worksChild Nutrition and Feed…1Child Nutrition and Feeding Issues: 1 fractional worksEconomic and Environmental Valuation: 1 fractional worksRNA Interference and Gene Delivery: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksMedical Coding and Health Information: 0 fractional works
PhysiologyRheumatologyEconomics and EconometricsClinical Psychology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lysosomal Storage Disorders Research Physiology 7 works
  2. 2 Glycogen Storage Diseases and Myoclonus Rheumatology 2 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  4. 4 COVID-19 and Mental Health Clinical Psychology 1 works
  5. 5 Child Nutrition and Feeding Issues Psychiatry and Mental health 1 works
  6. 6 Economic and Environmental Valuation Economics and Econometrics 1 works
  7. 7 RNA Interference and Gene Delivery Molecular Biology 1 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 1 works
  9. 9 Peptidase Inhibition and Analysis Oncology 1 works
  10. 10 Medical Coding and Health Information Health Information Management 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.3%not open68.7%

World: 28% of research is openly available.

with international co-authors29.6%domestic only70.4%

World: 19% is written across borders.

How has Amicus Therapeutics (United Kingdom)'s research output changed?

Output in 2018–2022 was 226% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gerrards Cross

All research institutions in Gerrards Cross

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.